us particularly from the optum ehr iqvia tm pharmetrics plus and iqvia tm ambulatory emr databases (Optum Inc)
Structured Review

Us Particularly From The Optum Ehr Iqvia Tm Pharmetrics Plus And Iqvia Tm Ambulatory Emr Databases, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ehr+-+emr/ehr+optum/pmc12863472-108-26-30
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching"
Article Title: Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching
Journal: PLOS One
doi: 10.1371/journal.pone.0341745
Figure Legend Snippet: CCAE, commercial claims and encounters; CDM, Clinformatics ® Data Mart; EHR, electronic health record; EMR, electronic medical record; LASSO, least absolute shrinkage and selection operator; MDC, medical data center; MDCD, multi-state Medicaid database; MDCR, Medicare supplemental; PH, proportional hazards; T2DM, type 2 diabetes mellitus.
Techniques Used: Selection
Figure Legend Snippet: CDM, Clinformatics ® Data Mart; CCAE, commercial claims and encounters; EHR, electronic health record; EMR, electronic medical record; MDC, medical data center; MDCD, multi-state Medicaid database; MDCR, Medicare supplemental.
Techniques Used:
Figure Legend Snippet: CDM, Clinformatics ® Data Mart; CCAE, commercial claims and encounters; EHR, electronic health record; EMR, electronic medical record; MDC, medical data center; MDCD, multi-state Medicaid database; MDCR, Medicare supplemental; PY, person-year.
Techniques Used:
Figure Legend Snippet: CDM, Clinformatics ® Data Mart; CCAE, commercial claims and encounters; EHR, electronic health record; EMR, electronic medical record; MDC, medical data center; MDCD, multi-state Medicaid database; MDCR, Medicare supplemental.
Techniques Used:
Related Articles
Selection:Article Title: Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching Article Snippet: The analyses were conducted for 4 specific AHAs using data from 7 US databases and 1 Japanese database, with the majority of patients coming from the Article Title: Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI’s “big data for better outcomes” program Article Snippet: Derivative Assay:Article Title: Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching Article Snippet: The analyses were conducted for 4 specific AHAs using data from 7 US databases and 1 Japanese database, with the majority of patients coming from the Article Title: Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI’s “big data for better outcomes” program Article Snippet: Biomarker Discovery:Article Title: Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching Article Snippet: The analyses were conducted for 4 specific AHAs using data from 7 US databases and 1 Japanese database, with the majority of patients coming from the Article Title: Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI’s “big data for better outcomes” program Article Snippet: Medications:Article Title: Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching Article Snippet: The analyses were conducted for 4 specific AHAs using data from 7 US databases and 1 Japanese database, with the majority of patients coming from the Article Title: Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI’s “big data for better outcomes” program Article Snippet: Software:Article Title: Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching Article Snippet: The analyses were conducted for 4 specific AHAs using data from 7 US databases and 1 Japanese database, with the majority of patients coming from the Article Title: Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI’s “big data for better outcomes” program Article Snippet: |
a ." width="250" height="auto" />